MichaelE.CoatsMD

PubMed

• 34 citations
  Eight-year immunogenicity and safety of interferon beta-1a-Avonex treatment in patients with multiple sclerosis.
  Robert M. Herndon, Richard A. Rudick, Frederick Munschauer, Michele Mass, Andres M. Salazar, Michael E. Coats, Robert Labutta, John R. Richert, Stanley Cohan, Claude P...> ;Multiple Sclerosis Journal. 2005 Aug 1
• Understanding of informed consent by demented individuals.
  Buckles VD, Powlishta KK, Palmer JL, Coats M, Hosto T, Buckley A, Morris JC> ;Neurology. 2003-12-23
• 10 citations
  Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials
  Donald E. Goodkin, Roger L. Priore, K. E. Wende, M. Campion, Dennis Bourdette, Robert M. Herndon, J. S. Fischer, Lawrence Jacobs, Diane L. Cookfair, Richard A. Rudick,...> ;Multiple Sclerosis Journal. 1998 Dec 1
• 87 citations
  Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis
  Richard A. Rudick, N. A. Simonian, J. A. Alam, M. Campion, James Scaramucci, Wendy Jones, Michael E. Coats, Donald E. Goodkin, Bianca Weinstock-Guttman, Robert M. Hern...> ;Neurology. 1998 May 1
• Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
  Rudick RA, Goodkin DE, Jacobs LD, Cookfair DL, Herndon RM, Richert JR, Salazar AM, Fischer JS, Granger CV, Simon JH, Alam JJ, Simonian NA, Campion MK, Bartoszak DM, Bo...> ;Neurology. 1997-08-01
• Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience.
  Morris JC, Ernesto C, Schafer K, Coats M, Leon S, Sano M, Thal LJ, Woodbury P> ;Neurology. 1997-06-01
• Cross-national interrater reliability of dementia diagnosis in the elderly and factors associated with disagreement.
  O'Connor DW, Blessed G, Cooper B, Jonker C, Morris JC, Presnell IB, Ames D, Kay DW, Bickel H, Schäufele M, Wind A, Coats M, Berg L> ;Neurology. 1996-11-01
• 1372 citations
  Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis
  Lawrence Jacobs, Diane L. Cookfair, Richard A. Rudick, Robert M. Herndon, John R. Richert, Andres M. Salazar, J. S. Fischer, Donald E. Goodkin, Carl V. Granger, Jack H...> ;Annals of Neurology. 1996 Mar 1
• Reliability of clinical nurse specialists in the staging of dementia.
  McCulla MM, Coats M, Van Fleet N, Duchek J, Grant E, Morris JC> ;Arch. Neurol.. 1989-11-01
• Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.
  Rudick, R. A., Cookfair, D. L., Simonian, N. A., Ransohoff, R. M., Richert, J. R., Jacobs, L. D., Herndon, R. M., Salazar, A. M., Fischer, J. S., Granger, C. V., Goodk...> ;J Neuroimmunol. 1999 Jan 1
• Progressive slowing of reaction time and increasing cerebrospinal fluid concentrations of quinolinic acid in HIV-infected individuals.
  Martin, A., Heyes, M. P., Salazar, A. M., Kampen, D. L., Williams, J., Law, W. A., Coats, M. E., Markey, S. P.> ;J Neuropsychiatry Clin Neurosci. 1992
• Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. 1997.
  Rudick, R. A., Goodkin, D. E., Jacobs, L. D., Cookfair, D. L., Herndon, R. M., Richert, J. R., Salazar, A. M., Fischer, J. S., Granger, C. V., Simon, J. H., Alam, J. J...> ;Neurology. 2001 Dec
• Join now to see all

Journal Articles

• Longitudinal study of EEG and evoked potentials in neurologically asymptomatic HIV infected subjects.  
  Jabbari B, Coats M, Salazar AM, Martin A, Scherockman B, Law WA, EEG and Clinical Neurophysiology, 86:145-151
• A phase III trail of intramuscular recombinant interferon beta for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics ...  
  Jacobs LD, Cookfair DL, Rudick RA, Herdon RM, Richert JR, Salazar AM, Fischer JS, Goodkin DE, Granger CV, Simon JH, Emrich LJ, Bartoszak DM, Bourdette DN, Braiman J, B..., Multiple Sclerosis, 1:118-135
• Magnetic Resonance Studies of Intramuscular Interferon B-1a for Relapsing Multiple Sclerosis.  
  Simon JH, Jacobs LD, Campion MK, Wende K, Simonian NA, Cookfair DL, Rudick RA, Herdon RM, Richert JR, Salazar AM, Alam JJ, Fischer JS, Goodkin DE, Granger CV, Lajaunie..., Annals of Neurology; 43:79-87
• Eight year immunogenicity and safety of interferon beta Ia-Avonex treatment of patients with Multiple Sclerosis.  
  Herndon RM, Rudick RA, Munschauer FE 3rd, Mass MK, Salazar AM, Coats ME, Labutta R, Richert JR, Cohan SL, Genain C, Goodkin D, Toal M, Riester K, Mult Scler; 11(4):409-19
• Join now to see all

Abstracts/Posters

• Neurologic findings in early HIV infection.
  Coats M, Salazar AM, Martin A, Jabbari B, Geyer C, Burke D, and the Walter Reed Retrovirus Research Group, V International Conference on AIDS p459, Montreal
• Neurobehavioral studies in early HIV infection.
  Salazar AM, Martin A, Coats M, Williams J, Law W, Roller T, Graves M, Gomez C, IV Panamerican Symposium of Neuroepidemiology, Colombia
• Serial evoked potential studies in early human immune deficiency virus infection.
  Coats M, Jabbari B, Martin A, Salazar AM, American Academy of Neurology, Miami Beach, Florida
• Neurologic findings in early HIV infection: A prospective study.
  Coats M, Salazar AM, Martin A, Williams J, Brown D, Jabbari B, Brown H, Graves M, VI International Conference on AIDS #FB 367, 169, San Francisco, California
• Progressive slowing of reaction time and increasing levels of cerebrospinal fluid quinolinic acid in HIV + subjects.
  Martin A, Heyes MP, Salazar AM, Williams J, Law W, Roller T, Kampen D, Coats M, Markey SP, VI International conference on AIDS #FB 397, 177, San Francisco, California
• Progressive motor and cognitive slowing HIV + subjects: Possible relation to quinolinic acid.
  Martin A, Heyes MP, Salazar AM, Williams J, Law W, Roller T, Kampen D, Coats M, Markey SP, Neurological and Neuropsychological Complications of HIV Infection, Monterey, California
• Somatosensory evoked potentials in neurologically intact HIV infected subjects.
  Jabbari B, Coats M, Duncan M, Salazar AM, Martin A, European Congress of Neurophysiology, Paris
• Significance of Serum Neutralising Antibodies to Avonex (IFNB-1a) in Multiple Sclerosis.
  Rudick R, Jones W, Alam J, Simonian N, Campion M Jacobs L, Herndon R, Richert J, Salazar AM, Cookfair D, Simon J, Coats M, Goodkin D, Mass M, and the MSCRG, American Academy of Neurology, Boston
• Join now to see all